Novel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display

Journal of Peptide Science

Volumn 21, Issue 4, 2015, Pages 265-273

  Khemthongcharoen, Numfon ^a,b   Ruangpracha, Athisake ^a,b   Sarapukdee, Pongsak ^a,b   Rattanavarin, Santi ^a,b   Jolivot, Romuald ^c   Jarujareet, Ungkarn ^a,b   Plaimas, Kitiporn ^b   Bhattarakosol, Parvapan ^b   Patumraj, Suthiluk ^b   Piyawattanametha, Wibool ^d  

^a NATIONAL ELECTRONICS AND COMPUTER TECHNOLOGY CENTER   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c BANGKOK UNIVERSITY   (Thailand)

^d KING MONGKUT'S INSTITUTE OF TECHNOLOGY LADKRABANG   (Thailand)

Author keywords

cervical cancer; p16; peptide protein docking; phage display; surface alignment

Indexed keywords

PROTEIN P16; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PEPTIDE LIBRARY; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; BIOPANNING; CANCER DIAGNOSIS; CLONE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; MOLECULAR DIAGNOSIS; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; CELL LINE; CHEMISTRY; METABOLISM; MOLECULAR DOCKING; NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; MOLECULAR DOCKING SIMULATION; NEOPLASMS; PEPTIDE LIBRARY; PROTEIN BINDING;

EID: 84924907523     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2726     Document Type: Article

References (37)

1. Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini P, Donnorso RP, Vocaturo A,. Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions. Mod. Pathol. 2006; 19: 384-391.
2. Romagosa C, Simonetti S, Lopez-Vicente L, Mazo A, Lleonart ME, Castellvi J, Ramon y Cajal S,. p164a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 2011; 30: 2087-2097.
3. Huang LW, Lee CC,. P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas. J. Clin. Pathol. 2012; 65: 117-121.
4. Zhang Q, Kuhn L, Denny LA, De Souza M, Taylor S, Wright TC, Jr,. Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int. J. Cancer 2007; 120: 351-356.
5. Ma C, Lewis J,. Small biopsy specimens reliably indicate p16 expression status of oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012; 6: 208-215.
6. Thomas J, Primeaux T,. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann. Diagn. Pathol. 2012; 16: 91-99.
7. Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES,. The meaning of p16ink4a expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 2011; 10: 2497-2503.
8. Crum CP, Abbott DW, Quade BJ,. Cervical cancer screening: from the papanicolaou smear to the vaccine era. J. Clin. Oncol. 2003; 21: 224-230.
9. Queiroz C, Silva TC, Alves VA, Villa LL, Costa MC, Travassos AG, Filho JB, Studart E, Cheto T, de Freitas LA,. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol. Res. Pract. 2006; 202: 77-83.
10. Redman R, Rufforny I, Liu C, Wilkinson EJ, Massoll NA,. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix. Arch. Pathol. Lab. Med. 2008; 132: 795-799.
11. Gurrola-Diaz CM, Suarez-Rincon AE, Vazquez-Camacho G, Buonocunto-Vazquez G, Rosales-Quintana S, Wentzensen N, von Knebel Doeberitz M,. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol. Oncol. 2008; 111: 120-124.
12. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M,. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 2002; 26: 1389-1399.
13. Pande J, Szewczyk MM, Grover AK,. Phage display: concept, innovations, applications and future. Biotechnol. Adv. 2010; 28: 849-858.
14. Rodi DJ, Agoston GE, Manon R, Lapcevich R, Green SJ, Makowski L,. Identification of small molecule binding sites within proteins using phage display technology. Comb. Chem. High Throughput Screen. 2001; 4: 553-572.
15. Kally KA, Waterman P, Weissleder R,. In vivo imaging of molecularly targeted phage. Neoplasia 2006; 8: 1011-1018.
16. Abràmaff MD, Magalhães PJ, Ram SJ,. Image processing with ImageJ. Biophotonics Int. 2004; 11: 36-42.
17. Néron B, Ménager H, Maufrais C, Joly N, Maupetit J, Letort S, Tuffery P, Letondal C,. Mobyle: a new full web bioinformatics framework. Bioinformatics 2009; 25: 3005-3011.
18. Duhovny D, Nussinov R, Wolfson H,. Efficient unbound docking of rigid molecules. Proceedings of the 2'nd Workshop on Algorithms in Bioinformatics(WABI), Gusfield I, et al. (ed.). Springer, Verlag: Rome, Italy, 2002; 185-200.
19. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ,. PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Res. 2005; 33: 363-367.
20. Huang X, Miller W,. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 1991; 12: 337-357.
21. Negi SS, Braun W,. Automated detection of conformational epitopes using phage display peptide sequences. Bioinform Biol. Insights. 2009; 3: 71-81.
22. Huang J, Ru B, Zhu P, Nie F, Yang J, Wang X, Dai P, Lin K, Guo FB,. MimoDB 2.0: a mimotope database and beyond. Nucleic Acids Res. 2011; 40: 271-277.
23. Ru B, Huang J, Dai P, Li S, Xia Z, Ding H, Lin H, Guo FB, Wang X,. MimoDB: a new repository for mimotope data derived from phage display technology. Molecules 2010; 15: 8279-8288.
24. Huang J, Ru B, Dai P,. Bioinformatics resources and tools for phage display. Molecules 2011; 16: 694-709.
25. Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ,. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008; 36: 229-232.
26. Andrusier N, Nussinov R, Wolfson HJ,. FireDock: fast interaction refinement in molecular docking. Proteins 2007; 69: 139-159.
27. Russo AA, Tong L, Lee J-O, Jeffrey PD, Pavletich NP,. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 1998; 395: 237-243.
28. Li J, Mahajan A, Tsai M-D,. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 2006; 45: 15168-15178.
29. Li J, Poi MJ, Tsai M-D,. Regulatory mechanisms of tumor suppressor P16INK4A and their relevance to cancer. Biochemistry 2011; 50: 5566-5582.
30. Mahajan A, Guo Y, Yuan C, Weghorst CM, Tsai M-D, Li J,. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. J. Mol. Biol. 2007; 373: 990-1005.
31. Newton JR, Kelly KA, Mahmood U, Weissleder R, Deutscher SL,. In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 2006; 8: 772-780.
32. Bar H, Yacoby I, Benhar I,. Killing cancer cells by targeted drug-carrying phage nanomedicines. BMC Biotechnol. 2008; 8: 37.
33. Deutscher SL,. Phage display in molecular imaging and diagnosis of cancer. Chem. Rev. 2010; 110: 3196-3211.
34. Brown KC,. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr. Pharm. Design 2010; 16: 1040-1054.
35. Lee S, Xie J, Chen X,. Peptide-based probes for targeted molecular imaging. Biochemistry 2010; 49: 1364-1376.
36. Miller SJ, Joshi BP, Feng Y, Gaustad A, Fearon ER, Wang TD,. In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe. PLoS One 2011; 6: e17384.
37. DeLano WL,. The PyMOL Molecular Graphics System (2002) DeLano Scientific San Carlos, CA, USA. http://www.pymol.org. 2002